Main
>
ONCOLOGY (**)
>
Lung>NSCLC>MET>PD-L1+>> ***
>
Treatment
>
UK. A. DurvaluMAb ***
UK. A. DurvaluMAb ***'s subsections
(*) USA Approval Date: 2018. 02.19.
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2018. 10.23.
TradeMark
TradeMark Web-Site
UK. A. DurvaluMAb ***'s products
This section has no products
(*) USA Approval Date: 2018. 02.19.
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2018. 10.23.
TradeMark
TradeMark Web-Site